Etomidate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Etomidate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Oct 5, 2022.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9507-10
Dosage Form
Injection
Presentation
Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10)
Initial Posting
Oct 5, 2022

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.